PD-L1, fibrosis, and immunotherapy in hepatocellular carcinoma: the importance of a scientific method to explore observations and answer questions

Surg Today. 2020 Oct;50(10):1318-1319. doi: 10.1007/s00595-020-01965-0. Epub 2020 Jan 31.
No abstract available

Keywords: Cancer; Fibrosis; Immunotherapy; Liver; PD-L1.

Publication types

  • Letter
  • Comment

MeSH terms

  • B7-H1 Antigen
  • Carcinoma, Hepatocellular* / therapy
  • Fibrosis
  • Humans
  • Immunotherapy
  • Liver Neoplasms* / therapy

Substances

  • B7-H1 Antigen